Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2
- PMID: 2425014
- DOI: 10.1089/jir.1986.6.143
Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2
Abstract
The effect of human interferons (IFNs) (alpha, beta, and gamma) on the in vitro replication of AIDS viruses (LAV, HTLV-III, and ARV-2) in human peripheral blood lymphocytes was investigated. At the time of peak virus production, IFN-alpha preparations (leukocyte, Namalwa, alpha 1, and alpha 2) at 100 U/ml, suppressed LAV, HTLV-III, and ARV-2 replication as measured by reverse transcriptase (RT) activity by greater than 50%. This suppression was dose dependent and high dosages (500 U/ml) of IFN-alpha resulted in almost complete suppression of RT activities (77-99%). A low dose (100 U/ml) of IFN-beta suppressed all three AIDS viruses by 75%. In contrast, human IFN-gamma at a dose range from 100 U/ml to 500 U/ml had no significant effect on the production of infectious viruses. These results indicate that only IFN-alpha and -beta are effective against LAV, HTLV-III, and ARV-2 replication. A continuous supply of IFN appeared to be essential for the constant suppression of RT activity. In fact, upon termination of single IFN treatment, enhanced virus production resulted.
Similar articles
-
Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.Science. 1986 May 30;232(4754):1135-7. doi: 10.1126/science.3010464. Science. 1986. PMID: 3010464
-
Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.Lancet. 1985 Mar 16;1(8429):602-4. doi: 10.1016/s0140-6736(85)92144-0. Lancet. 1985. PMID: 2857946
-
Implications of the discovery of HTLV-III for the treatment of AIDS.Cancer Res. 1985 Sep;45(9 Suppl):4685s-4688s. Cancer Res. 1985. PMID: 2410113 Clinical Trial.
-
Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.Cancer Res. 1985 Sep;45(9 Suppl):4677s-4684s. Cancer Res. 1985. PMID: 2410112 Review.
-
Prospects of therapy for infections with human T-lymphotropic virus type III.Ann Intern Med. 1985 Nov;103(5):750-5. doi: 10.7326/0003-4819-103-5-750. Ann Intern Med. 1985. PMID: 2413793 Review.
Cited by
-
Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.Antimicrob Agents Chemother. 1991 Jan;35(1):62-7. doi: 10.1128/AAC.35.1.62. Antimicrob Agents Chemother. 1991. PMID: 1707604 Free PMC article.
-
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.J Virol. 1992 Mar;66(3):1321-8. doi: 10.1128/JVI.66.3.1321-1328.1992. J Virol. 1992. PMID: 1738192 Free PMC article.
-
Pathogenesis of human immunodeficiency virus infection and prospects for control.Yale J Biol Med. 1987 Nov-Dec;60(6):589-600. Yale J Biol Med. 1987. PMID: 3324508 Free PMC article. Review.
-
Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon.Proc Natl Acad Sci U S A. 1989 Jul;86(13):4958-62. doi: 10.1073/pnas.86.13.4958. Proc Natl Acad Sci U S A. 1989. PMID: 2472636 Free PMC article.
-
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha.Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17453-8. doi: 10.1073/pnas.0707244104. Epub 2007 Oct 23. Proc Natl Acad Sci U S A. 2007. PMID: 17956986 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical